The Rise and Strain of BioNTech: Pioneering Cancer Research Amid Financial Turbulence
BioNTech faces reduced profits and revenues after pandemic vaccine demand subsides. The company reported a net loss of approximately €700 million in 2024 with income per share at €1.08. Future…